Pan-cancer Trna-Derived Fragment CAT1 Coordinates RBPMS to Stabilize NOTCH2 Mrna to Promote Tumorigenesis.

Mengqian Yu,Jiani Yi,Qiongzi Qiu,Dongxia Yao,Jia Li,Juze Yang,Chunyi Mi,Liyuan Zhou,Bingjian Lu,Weiguo Lu,Kejing Ying,Wantao Chen,Enguo Chen,Honghe Zhang,Zhimin Lu,Yan Lu,Pengyuan Liu
DOI: https://doi.org/10.1016/j.celrep.2023.113408
IF: 8.8
2023-01-01
Cell Reports
Abstract:Transfer RNA-derived fragments (tRFs) are a class of small non-coding regulatory RNAs that are involved in the pathophysiology of many diseases. However, the role of tRFs in cancer progression remains largely elusive. Here, we demonstrate that a pan-cancer 3'-tRF, CAT1 (cancer associated tRF 1), is ubiquitously up -regulated in tumors and associated with poor prognosis of a variety of cancers, including lung cancer. The upregulated CAT1 in cancer cells binds to RNA-binding protein with multiple splicing (RBPMS) and displaces NOTCH2 association from RBPMS, thereby inhibiting the subsequent CCR4-NOT deadenylation-complex-mediated NOTCH2 mRNA decay. The CAT1-enhanced NOTCH2 expression promotes lung cancer cell pro-liferation and metastasis in vitro and in vivo. In addition, plasma CAT1 levels are substantially increased in patients with lung cancer compared to non-cancer control subjects. Our findings reveal an intrinsic connec-tion between cancer-specific upregulation of CAT1 and cancer progression, show the regulation of NOTCH signaling in cancer by a 3'-tRF, and highlight its great clinical potential.
What problem does this paper attempt to address?